| Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes SA Brown, BP Kovatchev, D Raghinaru, JW Lum, BA Buckingham, ... New England Journal of Medicine 381 (18), 1707-1717, 2019 | 936 | 2019 |
| Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial GP Forlenza, Z Li, BA Buckingham, JE Pinsker, E Cengiz, RP Wadwa, ... Diabetes care 41 (10), 2155-2161, 2018 | 268 | 2018 |
| Turner Syndrome: updating the paradigm of clinical care JE Pinsker The Journal of Clinical Endocrinology & Metabolism 97 (6), E994-E1003, 2012 | 214 | 2012 |
| Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ... Diabetes care 44 (7), 1630-1640, 2021 | 212 | 2021 |
| Randomized crossover comparison of personalized MPC and PID control algorithms for the artificial pancreas JE Pinsker, JB Lee, E Dassau, DE Seborg, PK Bradley, R Gondhalekar, ... Diabetes care 39 (7), 1135-1142, 2016 | 181 | 2016 |
| A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk MJ Redondo, S Geyer, AK Steck, S Sharp, JM Wentworth, MN Weedon, ... Diabetes care 41 (9), 1887-1894, 2018 | 161 | 2018 |
| Feasibility of long-term closed-loop control: a multicenter 6-month trial of 24/7 automated insulin delivery B Kovatchev, P Cheng, SM Anderson, JE Pinsker, F Boscari, ... Diabetes Technology & Therapeutics 19 (1), 18-24, 2017 | 151 | 2017 |
| Real-world patient-reported outcomes and glycemic results with initiation of control-IQ technology JE Pinsker, L Müller, A Constantin, S Leas, M Manning, ... Diabetes technology & therapeutics 23 (2), 120-127, 2021 | 134 | 2021 |
| Multinational home use of closed-loop control is safe and effective SM Anderson, D Raghinaru, JE Pinsker, F Boscari, E Renard, ... Diabetes care 39 (7), 1143-1150, 2016 | 120 | 2016 |
| Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial E Isganaitis, D Raghinaru, L Ambler-Osborn, JE Pinsker, BA Buckingham, ... Diabetes Technology & Therapeutics 23 (5), 342-349, 2021 | 101 | 2021 |
| Diabetes Monitoring Using Smart Device JE Pinsker US Patent App. 13/911,137, 2013 | 99 | 2013 |
| Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia E Dassau, JE Pinsker, YC Kudva, SA Brown, R Gondhalekar, ... Diabetes Care 40 (12), 1719-1726, 2017 | 88 | 2017 |
| Adjustment of open-loop settings to improve closed-loop results in type 1 diabetes: a multicenter randomized trial E Dassau, SA Brown, A Basu, JE Pinsker, YC Kudva, R Gondhalekar, ... The Journal of Clinical Endocrinology & Metabolism 100 (10), 3878-3886, 2015 | 82 | 2015 |
| Safety and feasibility of the OmniPod hybrid closed-loop system in adult, adolescent, and pediatric patients with type 1 diabetes using a personalized model predictive control … BA Buckingham, GP Forlenza, JE Pinsker, MP Christiansen, RP Wadwa, ... Diabetes technology & therapeutics 20 (4), 257-262, 2018 | 76 | 2018 |
| Techniques for exercise preparation and management in adults with type 1 diabetes JE Pinsker, A Kraus, D Gianferante, BE Schoenberg, SK Singh, H Ortiz, ... Canadian journal of diabetes 40 (6), 503-508, 2016 | 74 | 2016 |
| Application of zone model predictive control artificial pancreas during extended use of infusion set and sensor: a randomized crossover-controlled home-use trial GP Forlenza, S Deshpande, TT Ly, DP Howsmon, F Cameron, N Baysal, ... Diabetes Care 40 (8), 1096-1102, 2017 | 64 | 2017 |
| Outpatient closed-loop control with unannounced moderate exercise in adolescents using zone model predictive control LM Huyett, TT Ly, GP Forlenza, S Reuschel-DiVirgilio, LH Messer, ... Diabetes technology & therapeutics 19 (6), 331-339, 2017 | 64 | 2017 |
| The Pacific Asynchronous TeleHealth (PATH) system: review of 1,000 pediatric teleconsultations CB Mahnke, CP Jordan, E Bergvall, DA Person, JE Pinsker Telemedicine and e-Health 17 (1), 35-39, 2011 | 63 | 2011 |
| Future artificial pancreas technology for type 1 diabetes: what do users want? KD Barnard, JE Pinsker, N Oliver, A Astle, E Dassau, D Kerr Diabetes Technology & Therapeutics 17 (5), 311-315, 2015 | 60 | 2015 |
| A review of biomarkers in the context of type 1 diabetes: biological sensing for enhanced glucose control KL Wolkowicz, EM Aiello, E Vargas, H Teymourian, F Tehrani, J Wang, ... Bioengineering & Translational Medicine 6 (2), e10201, 2021 | 59 | 2021 |
Eyal DassauHarvard John A. Paulson School of Engineering and Applied SciencesZweryfikowany adres z seas.harvard.edu
